Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate

European Respiratory Journal

Volumn 28, Issue 5, 2006, Pages 1036-1041

  Rosias, P P ^a,b   Robroeks, C M ^a   Niemarkt, H J ^a   Kester, A D ^c   Vernooy, J H ^a   Suykerbuyk, J ^a   Teunissen, J ^a   Heynens, J ^b   Hendriks, H J ^a   Jobsis Q ^a   Dompeling, E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Coating; Cytokine; Exhaled breath condensate; Exhaled markers; Isoprostanes; Methodology

Indexed keywords

8 ISOPROSTANE; ALBUMIN; ALUMINUM; BIOLOGICAL MARKER; GLASS; POLITEF; POLYPROPYLENE; SILICONE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ALBUMINOID; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; SILICONE DERIVATIVE;

ADOLESCENT; ADULT; AIR ANALYSIS; AIRWAY CONDUCTANCE; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXPIRED AIR; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOMER; MALE; METHODOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; BREATH ANALYSIS; EQUIPMENT DESIGN; EVALUATION; IMMUNOLOGY; INSTRUMENTATION; MATERIALS TESTING; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALBUMINS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; DINOPROST; EQUIPMENT DESIGN; FEMALE; GLASS; HUMANS; MALE; MATERIALS TESTING; MIDDLE AGED; SILICONES;

EID: 33845370422     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00110305     Document Type: Article

References (26)

1. Scheideler L, Manke HG, Schwulera U, Inacker O, Hämmerle H. Detection of non-volatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778-784.
2. Baraldi E, Ghiro L, Piovan V, Carraro S, Zacchello F, Zanconato S. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88: 358-360.
3. Rosias PP, Dompeling E, Hendriks HJ, Heijnens JW, Donckerwolcke RA, Jöbsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol 2004; 15: 4-19.
4. Horváth I, Hunt J, Barnes PJ, on behalf of the ATS/ERS Task Force. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
5. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164: 731-737.
6. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722.
7. Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002; 23: 232-237.
8. Hunt J. Exhaled breath condensate: an evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110: 28-34.
9. Antczak A, Gorski P. Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002; 15: 317-323.
10. Jöbsis Q, Rosias PPR. Analysis of exhaled breath condensate in children. In: Montuschi P, ed. New Perspectives in Monitoring Lung Inflammation: Analysis of Exhaled Breath Condensate. London, CRC Press, 2005; pp. 105-111.
11. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003; 21: 177-186.
12. Montuschi P, Ragazzoni E, Valente S, et al. Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflamm Res 2003; 52: 502-507.
13. Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable? Eur Respir J 2004; 23: 183-184.
14. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled interleukin-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 2004; 505: 169-175.
15. Van Rensen ELJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. Am J Respir Crit Care Med 2002; 165: 1275-1279.
16. Rosias PP, Dompeling E, Dentener MA, et al. Childhood asthma: exhaled markers of airway inflammation, asthma control score and lung function tests. Pediatr Pulmonol 2004; 38: 107-114.
17. Rosias PPR, Robroeks C, Hendriks J, Dompeling E, Jöbsis Q. Exhaled breath condensate: a space odyssey, where no one has gone before. Eur Respir J 2004; 24: 189-190.
18. Asher MI, Keil U, Anderson HR, et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
19. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report Publication No. 95-3659. National Heart Lung and Blood Institute. Bethesda, National Institutes of Health, 1995.
20. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, Schouten EG, Dupont LJ, Temme EH. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004; 23: 189-192.
21. Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med 2006; 100: 34-38.
22. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165: 1290-1293.
23. Leung TF, Wong GW, Ko FW, et al. Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. Int Arch Allergy Immunol 2005; 137: 66-72.
24. Huszar E, Szabo Z, Jakab A, Barta I, Herjavecz I, Horvath I. Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays. Inflamm Res 2005; 54: 350-355.
25. Leung TF, Li CY, Lam CW, et al. The relation between obesity and asthmatic airway inflammation. Pediatr Allergy Immunol 2004; 15: 344-350.
26. Komatsu T, Oguro Y, Teramura Y, et al. Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier. Biochim Biophys Acta 2004; 1675: 21-31.